Organon (OGN) Amortizatization of Intangibles (2020 - 2026)

Organon (OGN) recorded quarterly Amortizatization of Intangibles of $47.0 million in Q1 2026, down 6.0% quarter-over-quarter from $50.0 million in Q4 2025, and down 6.0% on a YoY basis from $50.0 million in Q1 2025.

Organon (OGN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Organon's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $47.0 million for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 6.0% year-over-year to $47.0 million; the TTM figure through Mar 2026 stood at $202.0 million (up 24.69% YoY), while the FY2025 annual figure was $205.0 million, up 41.38% from the prior year.
  • Amortizatization of Intangibles was $47.0 million for Q1 2026 at Organon, down from $50.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $53.0 million in Q2 2025 to a low of $28.0 million in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $37.0 million across 5 years, with a median of $33.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles decreased 17.65% in 2022, then surged 55.88% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $28.0 million in 2022, then changed by 0.0% to $28.0 million in 2023, then jumped by 53.57% to $43.0 million in 2024, then grew by 16.28% to $50.0 million in 2025, then slipped by 6.0% to $47.0 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $47.0 million (Q1 2026), $50.0 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Gsk 93,162,528.78 Bn 93,162,523.82 Bn 7.76 Bn -
2 Eli Lilly 1,017.87 Bn 1,012.58 Bn 16.22 Bn -
3 Johnson & Johnson 575.51 Bn 553.46 Bn 15.96 Bn -
4 AbbVie 400.43 Bn 391.08 Bn 10.78 Bn 1.70 Bn
5 Merck 294.19 Bn 288.54 Bn 12.09 Bn 931.00 Mn
6 Amgen 182.41 Bn 170.37 Bn 5.87 Bn -
7 Gilead Sciences 150.97 Bn 143.24 Bn 5.52 Bn 596.00 Mn
8 Pfizer 145.75 Bn 132.97 Bn -1.21 Bn -
9 Bristol Myers Squibb 113.35 Bn 102.90 Bn 8.07 Bn -
10 Organon 3.48 Bn 2.37 Bn 783.00 Mn 47.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.00 Mn
Mar 31, 2026 47.00 Mn
Dec 31, 2025 50.00 Mn
Dec 31, 2025 50.00 Mn
Sep 30, 2025 52.00 Mn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 53.00 Mn
Jun 30, 2025 53.00 Mn
Mar 31, 2025 50.00 Mn
Mar 31, 2025 50.00 Mn
Dec 31, 2024 43.00 Mn
Dec 31, 2024 43.00 Mn
Sep 30, 2024 35.00 Mn
Sep 30, 2024 35.00 Mn
Jun 30, 2024 34.00 Mn
Jun 30, 2024 34.00 Mn
Mar 31, 2024 33.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 28.00 Mn
Dec 31, 2023 28.00 Mn